title: Evidence for population variation in TSC1 and TSC2 gene expression.
abstract: BACKGROUND
  Tuberous sclerosis complex (TSC) is an autosomal dominant neurogenetic disorder caused by mutations in one of two genes, TSC1 or TSC2, which encode the proteins hamartin and tuberin, respectively 123. Common features of TSC include intractable epilepsy, mental retardation, and autistic features. TSC is associated with specific brain lesions, including cortical tubers, subependymal nodules and subependymal giant cell astrocytomas. In addition, this disease frequently produces characteristic tumors, termed hamartomas, in the kidneys, heart, skin, retina, and lungs. Disease severity in TSC can be quite variable and is not determined by the primary mutation alone. In fact, there is often considerable variability in phenotype within single families, where all affected individuals carry the same mutation. Factors suspected to influence phenotype in TSC include the specific primary mutation, random occurrence of second-hit somatic mutations, mosaicism, "modifying genes", and environmental factors. In addition to these factors, we hypothesize that differences in mRNA expression from the non-mutated TSC allele, or possibly from the mutated allele, play a part in modifying disease severity. Common genetic variants that regulate mRNA expression have previously been shown to play important roles in human phenotypic variability, including disease susceptibility. A prediction based on this idea is that common regulatory variants that influence disease severity in TSC should be detectable in non-affected individuals.
  
  
  METHODS
  A PCR/primer extension assay was used to measure allele specific expression of TSC1 and TSC2 mRNAs in leukocytes isolated from normal volunteers. This assay can be used to measure "allelic expression imbalance" (AEI) in individuals by making use of heterozygous "marker" single nucleotide polymorphisms (SNPs) located within their mRNA.
  
  
  RESULTS
  In this study we show for the first time that TSC1 and TSC2 genes exhibit allele-specific differences in mRNA expression in blood leukocytes isolated from normal individuals.
  
  
  CONCLUSIONS
  These results support the possibility that allele-specific variation in TSC mRNA expression contributes to the variable severity of symptoms in TSC patients.
authors.affiliation: Neurology Research Department, Barrow Neurological Institute, Phoenix, AZ 85013, USA.
authors.forename: Garilyn M
authors.initials: GM
authors.lastname: Jentarra
authors.forename: Stephen G
authors.initials: SG
authors.lastname: Rice
authors.forename: Shannon
authors.initials: S
authors.lastname: Olfers
authors.forename: David
authors.initials: D
authors.lastname: Saffen
authors.forename: Vinodh
authors.initials: V
authors.lastname: Narayanan
mesh_terms: D015870:Gene Expression; D014644:Genetic Variation; D005828:Genetics, Population; D006801:Humans; D007962:Leukocytes / Q000378:metabolism; D009154:Mutation; D010641:Phenotype; D012333:RNA, Messenger / Q000378:metabolism; D014402:Tuberous Sclerosis / Q000235:genetics*; D000077004:Tuberous Sclerosis Complex 1 Protein; D000077005:Tuberous Sclerosis Complex 2 Protein; D025521:Tumor Suppressor Proteins / Q000235:genetics*
chemical_list: D012333:RNA, Messenger; C000624650:TSC1 protein, human; C000624653:TSC2 protein, human; D000077004:Tuberous Sclerosis Complex 1 Protein; D000077005:Tuberous Sclerosis Complex 2 Protein; D025521:Tumor Suppressor Proteins